Tata India Pharma & Healthcare Fund vs SBI Healthcare Opportunities Fund compare
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹3689 Cr | ₹1232 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 31 Dec 2004 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | Nifty Pharma TRI |
Turn Over | 32% | 26.49% |
Expense Ratio | 1.94 | 2.14 |
Manager | Pradeep Kesavan | Meeta Shetty |
ISIN Code | INF200K01446 | INF277K016A9 |
Exits Load | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | 4.66% | 4.52% |
6 Month | -0.64% | -3.56% |
1 Year | 20.59% | 14.06% |
3 Year | 29.7% | 25.49% |
5 Year | 24.66% | 22.35% |
SIP Return Analysis
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | 6.71% | 7.02% |
1 Year | 12.22% | 6.98% |
3 Year | 28.08% | 24.55% |
5 Year | 22.74% | 20% |
Rolling Lumpsum Returns
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 15.53% | 9.47% |
3 Year | 17.55% | 18.04% |
5 Year | 12.71% | 14.89% |
Risk Management
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 13.69% | 15.93% |
Sharp | 1.49% | 1.09% |
Beta | 0.84% | 0.99% |
Alpha | 4.62% | -1.23% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Pradeep Kesavan | Meeta Shetty |
Total AUM | ₹434274 Cr | ₹17847 Cr |
Funds Managed | 43 | 5 |
SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 11.92 | 11.41 |
Mid Cap | 27.87 | 32.34 |
Small Cap | 32.74 | 27.12 |
Large Cap | 27.47 | 29.13 |
Sector Allocation
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 3.92 | 9.16 |
Basic Materials | 6.02 | 2.37 |
Healthcare | 90.06 | 88.47 |
Top Comparisons
Nippon India Large Cap Fund- Growth Plan Bonus Option
3Y Returns18.29%
Edelweiss Large Cap Fund - Regular Plan - Growth Option
3Y Returns20.21%
BAJAJ FINSERV BANKING AND PSU FUND REGULAR PLAN GROWTH
3Y Returns0%
Nippon India Banking & PSU Fund - Growth Plan - Growth Option
3Y Returns7.58%
BANDHAN Bond Fund - Medium Term - Regular Plan - Growth
3Y Returns7.18%
Aditya Birla Sun Life Medium Term Plan - Growth - Regular Plan
3Y Returns14.9%
Aditya Birla Sun Life Money Manager Fund - Growth
3Y Returns7.53%
Aditya Birla Sun Life Money Manager Fund - Growth
3Y Returns7.53%